What is TTRX's cash ratio?

TTRX (TTRX) reported cash ratio of 2.2× in Q1 2026.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

TTRX TTRX Cash ratio

Cash ratio at other companies

Regeneron PharmaceuticalsREGN

0.6×-0.3×

Bausch Health CompaniesBHC

0.3×0.0×

Journey Medical CorporationDERM

0.7×+0.2×

PTH

Pelthos Therapeutics Inc.PTHS

1.3×+1.3×

Celldex TherapeuticsCLDX

0.7×+0.2×

Arcutis Biotherapeutics, Inc.ARQT

0.2×-0.4×

Other financials

Income statement

See full

Operating income-$1.2M-224%

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Cash flow

See full

Operating cash flow-$1.6M-448%

Valuation

See full

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Returns & leverage

See full

Return on equity-118.8%—

Debt / equity1×—

Current ratio2.2×—

Where this comes from

Calculated from TTRX’s reported figures.

cash and equivalents/total current liabilities=2.2×

Based on the most recent quarter.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TTRX's cash ratio?: TTRX (TTRX) reported cash ratio of 2.2× in Q1 2026.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.